glp-1 cirrhosis The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis glp-1 and liver disease New

2016 SUSTAIN-6 reported a reduction in major adverse cardiovascular events among high-risk participants, expanding research interest beyond glucose and weight

Comfort, convenience, and consistency should guide injection site selection, provided injections are performed correctly and sites are rotated

IV drip containing antioxidants like glutathione can help lighten skin complexion too

Long-term risks include: gallstones chronic gallbladder inflammation need for gallbladder removal (cholecystectomy) recurrent biliary pain Thyroid Tumor Risk (Black Box Warning) Several GLP-1 drugs carry an FDA boxed warning for thyroid C-cell tumors and Medullary Thyroid Carcinoma (MTC), based on long-term rodent studies

Glomerular mechanisms of proteinuria

Oct 2023;5(10):100704